Debio 0932 CTA
Debio 0932 CTA. Debiopharm's clinical trial applications (CTAs), for any and all studies concerning the Compound, including CTAs for the studies [**], including all amendments thereto, and the "Declaration of End of Trial" for each aforementioned study.
All Definitions
Found in
CURIS INC contract